Skip to content

Author

Zi-Hao Xu

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Integrated Multi-Omics and Experimental Evidence Implicates PDCD5 as a Candidate Gene Associated with Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disorder in which endoplasmic reticulum stress and mitochondrial dysfunction overlap with features associated with paraptosis. This study aimed to identify a paraptosis-related candidate gene for PBC via multi-omics integration and experimental valida...

Zi-Hao Xu, Yi-Fan Liu, Cong-Cong Cao et al. · 0 citations
Open access Sep 2026

Pasteurized Akkermansia muciniphila as a candidate multi-effector pharmacological system in the gut-liver axis: evidence, unresolved causality, and translational priorities

Pasteurized Akkermansia muciniphila is a clinically tractable postbiotic candidate, but its activity cannot be assigned to a single principle. Heat-stable Amuc_1100 is demonstrably retained in pasteurized cells, whereas the GLP-1-inducing protein P9, extracellular vesicles (AmEVs), membrane lipids, and diffusible m...

Yi-Fan Liu, Zi-Hao Xu, Dong-Seon Kim et al. · 0 citations
Aug 2026

FAM117B Promotes Malignant Progression of Hepatocellular Carcinoma by Forming a Bidirectional Regulatory Loop with NAT10 and Activating the JAK-STAT3 Pathway.

The molecular mechanism by which FAM117B promotes HCC progression via forming a bidirectional regulatory loop with NAT10 and activating the JAK-STAT3 signaling pathway through acetylation modification is revealed, providing a novel potential target and theoretical basis for targeted therapy of HCC.

Zhao-Hong Wang, Jian-Feng Fang, Lijun Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.